Post-transplant Hepatitis C
1 clinical trials · Condition
◉ Watch Post-transplant Hepatitis C
| Record | Firm | Date |
|---|---|---|
| Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C (NCT01779518) | Gilead Sciences |
Track Post-transplant Hepatitis C automatically
Every clearance here is in the API, with alerts when new ones post.